Innovative annatto-based therapy shows promise for treating pediatric halitosis

A study by researchers working in Brazil shows that antimicrobial photodynamic therapy in which blue light targets annatto colorant is a feasible and effective option for treatment of halitosis in mouth-breathing children.

Imbria touts PhII success in hypertrophic cardiomyopathy, adding fuel to overall efficacy profile

Imbria Pharmaceuticals’ partial fatty acid oxidation inhibitor improved outcomes in Phase II non-obstructive hypertrophic cardiomyopathy patients, with the company noting that the asset’s efficacy could

November 8, 2023

Congress is unprepared for the post-Chevron world. It needs help from subject matter experts

The U.S. Congress needs help. It lacks the expertise to do its job in the post-Chevron world. At the end of its most recent term,

August 6, 2024

Accreditation agencies take on telehealth with new virtual care standards

In the early days of the pandemic, as social distancing forced patients out of doctors’ offices, health care organizations scrambled to offer care online. In

April 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.